In this event, we focus on the Asia Pacific region, uncovering the landscape of animal welfare legislation and its implications for pharmaceutical and biotech players.
Gain insider insights from regional suppliers and delve into the specifics of Asia Pacific’s practices. This comprehensive overview aims to empower your organization to promote and uphold animal welfare without compromising ethical integrity or regulatory compliance.
Watch this comprehensive deep dive into animal welfare practices and legislation in the Asia Pacific region and gain valuable knowledge that could redefine your approach to animal welfare.
To access additional resources and handouts, please contact [email protected].
Head over to Part One (North America) or Part Three (Europe) for more!
Click to watch the webinar recording. To view the presentation full screen simply click the square icon located in the bottom-right corner of the video-viewer.
Presenters
Senior Director
In Vivo and GLP Services
Scientist.com
Meaghan Loy is currently the Senior Director of In Vivo and GLP Services at Scientist.com, a research marketplace that enables researchers to access pre-qualified assessed animal model suppliers as well as hundreds of suppliers that provide in vitro models that can potentially replace or reduce the use of in vivo models. She joined Scientist.com in 2018 and is an expert in the use of COMPLi®, Scientist.com’s award winning platform that introduces a common, comprehensive process and supply agreement supporting access to pre-qualified assessed suppliers of in vivo and in vitro research models and provides animal welfare compliance coverage.
Founder, President & CEO
Shanghai LIDE Co. Ltd. (LIDE)
Dr. Wen’s research foundation was 12 years at Millennium Pharmaceutical, Biogen-Idec in Boston, MA. In 2007, attracted by the innovation coming from overseas, she returned to China as VP of Biology at Shanghai ChemPartner. She founded Shanghai LIDE Biotech in 2011 to drive research and development in personalized precision medicine.
Additional Content From Scientist.com
How to Avoid Expensive Redesign Cycles in Antibody Discovery
Learn how integrated antibody discovery and engineering strategies can accelerate the path from hit to optimized lead in less than 12 months while minimizing costly redesign cycles.
Beyond Exposure: Integrating PK/PD for Translational Predictive Power
Learn to integrate PK/PD modeling and strategic biomarkers to bridge the translational gap. Improve clinical predictability for NCEs, ADCs, and large molecules in this technical webinar.
Advancing the Manufacture of Mesenchymal Stromal Cells and Derived Extracellular Vesicles in Stirred-Tank Bioreactors Through Enhanced Bioprocess Control
Learn how to scale the production of MSCs and extracellular vesicles using bioreactor control and real-time monitoring for more consistent therapies.